Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer.

The CD44 transmembrane glycoproteins play multifaceted roles in tumor progression and metastasis. CD44 expression has also been associated with stem-like breast cancer cells. Hypoxia commonly occurs in tumors and is a major cause of radiation and chemo-resistance. Hypoxia is known to inhibit differe...

Full description

Bibliographic Details
Main Authors: Balaji Krishnamachary, Marie-France Penet, Sridhar Nimmagadda, Yelena Mironchik, Venu Raman, Meiyappan Solaiyappan, Gregg L Semenza, Martin G Pomper, Zaver M Bhujwalla
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3429433?pdf=render
_version_ 1817994849541947392
author Balaji Krishnamachary
Marie-France Penet
Sridhar Nimmagadda
Yelena Mironchik
Venu Raman
Meiyappan Solaiyappan
Gregg L Semenza
Martin G Pomper
Zaver M Bhujwalla
author_facet Balaji Krishnamachary
Marie-France Penet
Sridhar Nimmagadda
Yelena Mironchik
Venu Raman
Meiyappan Solaiyappan
Gregg L Semenza
Martin G Pomper
Zaver M Bhujwalla
author_sort Balaji Krishnamachary
collection DOAJ
description The CD44 transmembrane glycoproteins play multifaceted roles in tumor progression and metastasis. CD44 expression has also been associated with stem-like breast cancer cells. Hypoxia commonly occurs in tumors and is a major cause of radiation and chemo-resistance. Hypoxia is known to inhibit differentiation and facilitates invasion and metastasis. Here we have investigated the effect of hypoxia on CD44 and two of its isoforms in MDA-MB-231 and SUM-149 triple negative human breast cancer cells and MDA-MB-231 tumors using imaging and molecular characterization.The roles of hypoxia and hypoxia inducible factor (HIF) in regulating the expression of CD44 and its variant isoforms (CD44v6, CD44v7/8) were investigated in human breast cancer cells, by quantitative real-time polymerase chain reaction (qRT-PCR) to determine mRNA levels, and fluorescence associated cell sorting (FACS) to determine cell surface expression of CD44, under normoxic and hypoxic conditions. In vivo imaging studies with tumor xenografts derived from MDA-MD-231 cells engineered to express tdTomato red fluorescence protein under regulation of hypoxia response elements identified co-localization between hypoxic fluorescent regions and increased concentration of (125)I-radiolabeled CD44 antibody.Our data identified HIF-1α as a regulator of CD44 that increased the number of CD44 molecules and the percentage of CD44 positive cells expressing variant exons v6 and v7/8 in breast cancer cells under hypoxic conditions. Data from these cell studies were further supported by in vivo observations that hypoxic tumor regions contained cells with a higher concentration of CD44 expression.
first_indexed 2024-04-14T01:57:33Z
format Article
id doaj.art-dec1857a58b74b2990b63b8d13a9b3e8
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-14T01:57:33Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-dec1857a58b74b2990b63b8d13a9b3e82022-12-22T02:18:58ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0178e4407810.1371/journal.pone.0044078Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer.Balaji KrishnamacharyMarie-France PenetSridhar NimmagaddaYelena MironchikVenu RamanMeiyappan SolaiyappanGregg L SemenzaMartin G PomperZaver M BhujwallaThe CD44 transmembrane glycoproteins play multifaceted roles in tumor progression and metastasis. CD44 expression has also been associated with stem-like breast cancer cells. Hypoxia commonly occurs in tumors and is a major cause of radiation and chemo-resistance. Hypoxia is known to inhibit differentiation and facilitates invasion and metastasis. Here we have investigated the effect of hypoxia on CD44 and two of its isoforms in MDA-MB-231 and SUM-149 triple negative human breast cancer cells and MDA-MB-231 tumors using imaging and molecular characterization.The roles of hypoxia and hypoxia inducible factor (HIF) in regulating the expression of CD44 and its variant isoforms (CD44v6, CD44v7/8) were investigated in human breast cancer cells, by quantitative real-time polymerase chain reaction (qRT-PCR) to determine mRNA levels, and fluorescence associated cell sorting (FACS) to determine cell surface expression of CD44, under normoxic and hypoxic conditions. In vivo imaging studies with tumor xenografts derived from MDA-MD-231 cells engineered to express tdTomato red fluorescence protein under regulation of hypoxia response elements identified co-localization between hypoxic fluorescent regions and increased concentration of (125)I-radiolabeled CD44 antibody.Our data identified HIF-1α as a regulator of CD44 that increased the number of CD44 molecules and the percentage of CD44 positive cells expressing variant exons v6 and v7/8 in breast cancer cells under hypoxic conditions. Data from these cell studies were further supported by in vivo observations that hypoxic tumor regions contained cells with a higher concentration of CD44 expression.http://europepmc.org/articles/PMC3429433?pdf=render
spellingShingle Balaji Krishnamachary
Marie-France Penet
Sridhar Nimmagadda
Yelena Mironchik
Venu Raman
Meiyappan Solaiyappan
Gregg L Semenza
Martin G Pomper
Zaver M Bhujwalla
Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer.
PLoS ONE
title Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer.
title_full Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer.
title_fullStr Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer.
title_full_unstemmed Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer.
title_short Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer.
title_sort hypoxia regulates cd44 and its variant isoforms through hif 1α in triple negative breast cancer
url http://europepmc.org/articles/PMC3429433?pdf=render
work_keys_str_mv AT balajikrishnamachary hypoxiaregulatescd44anditsvariantisoformsthroughhif1aintriplenegativebreastcancer
AT mariefrancepenet hypoxiaregulatescd44anditsvariantisoformsthroughhif1aintriplenegativebreastcancer
AT sridharnimmagadda hypoxiaregulatescd44anditsvariantisoformsthroughhif1aintriplenegativebreastcancer
AT yelenamironchik hypoxiaregulatescd44anditsvariantisoformsthroughhif1aintriplenegativebreastcancer
AT venuraman hypoxiaregulatescd44anditsvariantisoformsthroughhif1aintriplenegativebreastcancer
AT meiyappansolaiyappan hypoxiaregulatescd44anditsvariantisoformsthroughhif1aintriplenegativebreastcancer
AT gregglsemenza hypoxiaregulatescd44anditsvariantisoformsthroughhif1aintriplenegativebreastcancer
AT martingpomper hypoxiaregulatescd44anditsvariantisoformsthroughhif1aintriplenegativebreastcancer
AT zavermbhujwalla hypoxiaregulatescd44anditsvariantisoformsthroughhif1aintriplenegativebreastcancer